Vehement Finance News Network

Jyong Biotech has updated its market entry strategy for innovative botanical pharmaceuticals, establishing multiple competitive advantages for its new drug portfolio

Jyong Biotech Ltd. (Nasdaq stock code: MENS) (hereinafter referred to as “the Company” or “Jyong Biotech”) is a science-driven biotechnology company dedicated to developing and commercializing innovative plant-based therapies. The…

Continue Reading